News
Insights
Jobs
Career Advice
Companies
Hotbeds
More

SUBSCRIBE

SUBSCRIBE

News
Insights
Jobs
Career Advice
Companies
Hotbeds
More

Search Query

Search Results

Looking for jobs? Search jobs

9,461 Results

Type

Article (978)
Company Profile (1)
Press Release (8482)

Section

Business (3345)
Career Advice (16)
Deals (500)
Drug Delivery (2)
Drug Development (1433)
Employer Resources (7)
FDA (291)
Job Trends (405)
News (5554)
Policy (521)

Tag

Date

Today (1)
Last 7 days (10)
Last 30 days (49)
Last 365 days (468)
2024 (435)
2023 (460)
2022 (1106)
2021 (981)
2020 (851)
2019 (670)
2018 (391)
2017 (506)
2016 (454)
2015 (521)
2014 (357)
2013 (318)
2012 (345)
2011 (391)
2010 (310)

Location

Africa (13)
Arizona (2)
Asia (565)
Australia (76)
California (46)
Canada (2)
China (6)
Connecticut (3)
Europe (2296)
Indiana (3)
Japan (2)
Maryland (6)
Massachusetts (40)
Missouri (4)
New Jersey (9)
New York (40)
North Carolina (8)
Northern California (28)
Pennsylvania (4)
South America (17)
Southern California (17)
Utah (4)

Filters

Type

Article (978)
Company Profile (1)
Press Release (8482)

Section

Business (3345)
Career Advice (16)
Deals (500)
Drug Delivery (2)
Drug Development (1433)
Employer Resources (7)
FDA (291)
Job Trends (405)
News (5554)
Policy (521)

Tag

Date

Today (1)
Last 7 days (10)
Last 30 days (49)
Last 365 days (468)
2024 (435)
2023 (460)
2022 (1106)
2021 (981)
2020 (851)
2019 (670)
2018 (391)
2017 (506)
2016 (454)
2015 (521)
2014 (357)
2013 (318)
2012 (345)
2011 (391)
2010 (310)

Location

Africa (13)
Arizona (2)
Asia (565)
Australia (76)
California (46)
Canada (2)
China (6)
Connecticut (3)
Europe (2296)
Indiana (3)
Japan (2)
Maryland (6)
Massachusetts (40)
Missouri (4)
New Jersey (9)
New York (40)
North Carolina (8)
Northern California (28)
Pennsylvania (4)
South America (17)
Southern California (17)
Utah (4)

9,461 Results for "bayer".

Sort By

Clinical research

Bayer’s Kidney Disease Drug Kerendia Reduces Cardiovascular Risk by 16%

Bayer’s Kerendia, at the center of a $3 billion sales forecast, reduced the risk of cardiovascular death and heart failure in a Phase III trial.

September 3, 2024
·
2 min read
·
Annalee Armstrong
Earnings

Bayer Earnings ‘Not Pretty,’ CEO Bill Anderson Admits As He Urges Calm

Bayer reported a decline of 37% in earnings per share on Tuesday, which sent its stock down 12%. CEO Bill Anderson urged investors to be patient as the company executes on a performance-boosting strategy outlined in March.

November 12, 2024
·
2 min read
·
Annalee Armstrong
Layoffs

Bayer to Lay Off 150 in Basel, Switzerland

The Switzerland layoffs are the latest in Bayer’s 2024 workforce reductions, which already include 1,500 people and nearly half of the executive leadership team.

August 26, 2024
·
1 min read
·
Angela Gabriel
Startups

Roivant Creates New ‘Vant’ to License Bayer’s Pulmonary Hypertension Drug

Under an in-license agreement worth up to $294 million, Roivant Sciences gains exclusive worldwide rights from Bayer to develop and commercialize mosliciguat, a potential first-in-class inhaled soluble guanylate cyclase activator.

September 10, 2024
·
2 min read
·
Tristan Manalac
Layoffs

Bayer, J&J and Pfizer to Lay Off Nearly 500 Combined Employees

Big Pharma companies Bayer and Johnson & Johnson are downsizing their New Jersey workforces while Pfizer cuts jobs in Ireland. Many of the layoffs are effective by the end of the year.

October 2, 2024
·
3 min read
·
Angela Gabriel
Drug Development

Bayer’s Finerenone Hits Primary Endpoint in Phase III Heart Failure Trial

With the late-stage win, Bayer announced Monday that it plans to talk to regulators about seeking approval in an indication that is central to its $3 billion-plus peak sales forecast.

August 5, 2024
·
2 min read
·
Nick Paul Taylor
Earnings

Bayer Touts ‘Modest’ Q2 Performance Amid Sweeping Reorganization

Bayer’s surprising growth in the second quarter was driven in large part by two pharma products: the prostate cancer drug Nubeqa and the chronic kidney disease treatment Kerendia.

August 6, 2024
·
2 min read
·
Tristan Manalac
Press Releases

Bayer’s Receives FDA Clearance for MEDRAD® Centargo CT Injection System

November 7, 2024
·
5 min read
Bayer’s New Strategy, Novo Vs. Lilly and Psychedelics

Mass layoffs represent a step for Bayer toward reducing managerial layers, while clinical results released in the last week could influence the parallel races between Novo Nordisk and Eli Lilly in the GLP-1 and insulin spaces.

May 21, 2024
·
1 min read
·
Greg Slabodkin, Heather McKenzie, Tyler Patchen
Business

Bayer and Rad AI Announce Collaboration agreement

As experts from around the globe gather at the annual Society for Informatics in Medicine conference, Bayer and Rad AI are announcing a collaboration to bring Rad AI’s cutting edge AI radiology operational solutions to Calantic ™ Digital Solution customers.

June 27, 2024
·
5 min read

1 of 947

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.

Explore
About
More

© 1985 - 2024 BioSpace.com. All rights reserved.

twitter
instagram
facebook
linkedin